• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Actelion - Articles and news items

pulmonary arterial hypertension

FDA approves Uptravi for pulmonary arterial hypertension

Industry news / 23 December 2015 / Victoria White

Uptravi (selexipag) acts by relaxing muscles in the walls of blood vessels to dilate (open) blood vessels and decrease the elevated pressure in the vessels supplying blood to the lungs…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +